Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024.

Front Cell Infect Microbiol · 2026 · PMC13201249 · PMID 42205475

Europe PMC DOI

hedged sentence

0.0390

closest p · 0.8× alpha

0.0390

boldest claim

The sentences

moderately significantp = 0.039actually significant

Regarding Enterobacterales susceptibility to ceftolozane/tazobactam, the Cochran–Armitage test revealed a highly significant trend of increasing susceptibility among isolates from Kuwait ( p < 0.0001), but a decreasing trend in Qatar ( p < 0.0001), while a moderately significant decreasing trend in Oman was observed ( p = 0.039).

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.